Shihoko Komine-Aizawa

Dr. Shihoko Komine-Aizawa

Division of Microbiology, Nihon University, Tokyo, Japan
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2020 in Placenta
Verified
Journal Article
Closed access
SKShihoko Komine-Aizawa
Shihoko Komine-Aizawa
KTKazuhide Takada
Kazuhide Takada
SHSatoshi Hayakawa
Satoshi Hayakawa

24 August 2018 in American Journal of Reproductive Immunology
Verified
Journal Article
Closed access
PDF file
KTKazuhide Takada
Kazuhide Takada
SKShihoko Komine-Aizawa
Shihoko Komine-Aizawa
TKTomoya Kuramochi
Tomoya Kuramochi
SIShun Ito
Shun Ito
QTQuang Duy Trinh
Quang Duy Trinh
SHSatoshi Hayakawa
Satoshi Hayakawa

24 April 2017 in BMC Immunology
Verified
Journal Article
Open access
PDF file
KTKazuhide Takada
Kazuhide Takada
SKShihoko Komine-Aizawa
Shihoko Komine-Aizawa
NHNaoko Hirohata
Naoko Hirohata
QTQuang D Trinh
Quang D Trinh
ANAtsuyoshi Nishina
Atsuyoshi Nishina
SHSatoshi Hayakawa
Satoshi Hayakawa
Delayed wound healing reduces the quality of life (QOL) of patients. Thus, understanding the mechanism of wound healing is indispensable for better management. However, the role of innate immunity in wound healing is thus far unknown. Recently the involvement of TLR3 in wound healing has been evaluated. The systemic administration of polyriboinosinic-polyribocytidylic acid (poly I:C ; a substitute for viral dsRNA and a ligand of toll-like receptor 3), enhances wound healing in vivo. The aim of this study is to improve our understanding of the link between innate immunity and human wound healing, particularly in re-epithelialization. The present study showed that poly I:C significantly accelerated collective HaCaT cell migration in a scratch assay. Poly I:C also increased IL-8 and bFGF production, and anti-IL-8 antibodies significantly inhibited the migration caused by poly I:C. Human recombinant IL-8 also accelerated collective HaCaT cell migration. An immunofluorescence assay and enzyme-linked immunosorbent assay (ELISA) also revealed that poly I:C decreased E-cadherin protein levels and increased vimentin protein levels, and anti-IL-8 antibody reversed this effect. In contrast, nucleic/cytosolic protein ratios of Snail 1 were unchanged in all tested conditions. Our findings demonstrated that poly I:C accelerated collective HaCaT cell migration via autocrine/paracrine secretions of IL-8 and the subsequent incomplete epithelial-mesenchymal transition (EMT). Our findings provide a new strategy for wound healing by regulating innate immune systems in re-epithelialization.

10 July 2020 in Immunological Medicine
Verified
Journal Article
Open access
SKShihoko Komine-Aizawa
Shihoko Komine-Aizawa
SIShun Ito
Shun Ito
SAShu Aizawa
Shu Aizawa
TNTakahiro Namiki
Takahiro Namiki
SHSatoshi Hayakawa
Satoshi Hayakawa
Cow milk is a nourishing food containing numerous essential nutrients. In Japan, the consumption of cow milk is thought to enhance resistance to exhaustion-related diseases. Although several nutrients in cow milk, such as lactoferrin, are thought to modulate immune cells, the mechanisms remain unclear. Recently, the immunoregulatory functions of food-derived microRNAs or exosomes have been reported. Therefore, we studied the effects of exosomes derived from cow milk (CM-Exs) on immune cells in the present study. We obtained blood samples from healthy adult donors with the approval of the ethics committee. Peripheral blood mononuclear cells (PBMCs) were stimulated with CM-Exs in the absence or presence of interleukin-2 (IL-2) and IL-12. Cell surface markers and intracellular cytokine production were analysed by flow cytometry. CM-Ex stimulation enhanced the expression of CD69 on NK cells. Although CM-Ex stimulation alone did not induce interferon-γ (IFN-γ) production by NK cells or γδT cells, simultaneous stimulation with CM-Ex, IL-2 and IL-12 significantly enhanced IFN-γ production. In conclusion, cow milk consumption alone may not activate immune cells; however, CM-Exs could enhance immune cells under inflammatory conditions.

10 May 2022 in Journal of Obstetrics and Gynaecology Research
Verified
Journal Article
Closed access
SKShihoko Komine-Aizawa
Shihoko Komine-Aizawa
YHYasuo Haruyama
Yasuo Haruyama
MDMasashi Deguchi
Masashi Deguchi
SHSatoshi Hayakawa
Satoshi Hayakawa
KKKei Kawana
Kei Kawana
TSTakashi Sugiyama
Takashi Sugiyama

23 March 2021 in Journal of Obstetrics and Gynaecology Research
Verified
Journal Article
Open access
PDF file
SHSatoshi Hayakawa
Satoshi Hayakawa
SKShihoko Komine-Aizawa
Shihoko Komine-Aizawa
KTKazuhide Takada
Kazuhide Takada
TKTadashi Kimura
Tadashi Kimura
HYHideto Yamada
Hideto Yamada
The current COVID‐19 pandemic is a global concern. The recent introduction of vaccines has provided a reason for hope, but new problems, such as vaccine hesitancy, have arisen. One of the most important of these issues is the safety of vaccines for pregnant women. In this article, we collected worldwide indications for vaccination, including women who are pregnant or who wish to become pregnant, and reports of adverse reactions to COVID‐19 vaccination. The Japan Society of Obstetrics and Gynecology and the Japanese Society of Infectious Diseases in Obstetrics and Gynecology have published recommendations for the vaccination of pregnant women with a COVID‐19 vaccine. The guidelines are as follows: (1) pregnant women should not be excluded from vaccination; (2) informed consent should be obtained before vaccination; (3) healthcare workers and pregnant women with complications such as diabetes, hypertension, and obesity should be vaccinated preferentially; (4) vaccination should be avoided until 12 weeks of gestation during organogenesis; (5) spouse and family members should be vaccinated actively; and (6) nursing mothers are not particularly affected. This policy has been adopted in government guidelines. Additional efforts should be made to protect pregnant women from infection and severe illness with COVID‐19 by eliminating vaccine hesitancy.